Get started
Author

Abhishek J. Arora

Observed names: A. Arora, Abhishek Arora
ORCID: 0000-0002-1958-8188
Observed ORCID: 0000-0002-1958-8188
OpenAlex ID: A5121102837
A phase II, randomized, open-label study to evaluate low-dose pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy for localized triple-negative breast cancer (TNBC) (PLANeT trial—Pembrolizumab Low dose in Addition to NACT in TNBC)
2025 · A. Arora, H. Bhaskarane, et al. · Annals of Oncology · 11
FASI and Cognitive Dysfunction in Pediatric NF-1: A Case-Based Discussion
2026 · Mohit Kapoor, Annapurna Srirambhatla, et al. · Adolescent Psychiatry
Bilateral putamen necrosis in a case of dyskinetic movements and schizophrenia – A case report
2026 · Santhini Ajay, Diveesha Munipati, et al. · Indian Journal of Psychiatry
Evaluating the Quality of Telemedicine Consultations in India’s eSanjeevani Ayushman Bharat Health and Wellness Center Platform: Insights from a Prospective Observational Study
2026 · Abhishek J. Arora, Lakshmi Jyothi Tadi, et al. · Asian journal of public health practice.
Works count: 4
Citation count: 11
H-index: 1
I10-index: 1
Year
Topic
Type